In the concluding segment of this three-part series, Dr. Irfan Sheikh delves into the landscape of anti-seizure medications. In this last installment, his attention turns to Cannabidiol.

In the second part of this three-part series, Dr. Irfan Sheikh explores the realm of anti-seizure medications. In this installment, he shifts his focus to Perampanel.

In the first segment of a three-part series, Dr. Irfan Sheikh delves into the topic of anti-seizure medications. In today's installment, his focus will be on Cenobamate.

Drs. Divya Singhal and Myriam Abdennadher discuss their paper, "Work, Parenting, and Well-being. An International Survey of Neurologists During the COVID-19 Pandemic"

Show references: https://www.neurology.org/doi/10.1212/cpj.0000000000200176

Dr. Andrew Southerland talks with Dr. Franzi Herpich about her journey of experiencing a stroke in 2021.

Dr. Halley Alexander discusses the paper, "Treatment of seizures in the neonate: Guidelines and consensus-based recommendations-Special report from the ILAE Task Force on Neonatal Seizures".

Show references: https://pubmed.ncbi.nlm.nih.gov/37655702/

Max Goldman, Director of Congressional Affairs at the AAN, gives a year-end advocacy update.

Matt Kerschner, Director of Regulatory Affairs and Policy at the AAN, gives a year-end advocacy update.

Dr. Adam de Havenon talks with Dr. Gustaf Edgren about the potential transmissible risk associated with some types of spontaneous intracerebral hemorrhage in patients who receive transfusions.

Dr. Elizabeth Coon talks with Dr. Mitchell G. Miglis about the frequency of orthostatic hypotension in isolated REM sleep behavior disorder.

Read the related article in Neurology.